bioRxivScientific Communication & Education
Predicting long-term Type 2 Diabetes with Support Vector Machine using Oral Glucose Tolerance Test
H. T. Abbas, L. Alic, M. Erraguntla, M. Abdul-Ghani, Q. Abbasi, M. Qaraqe
Abstract
Diabetes is a large healthcare burden worldwide. There is substantial evidence that lifestyle modifications and drug intervention can prevent diabetes, therefore, an early identification of high risk individuals is important to design targeted prevention strategies. In this paper, we present an automatic tool that uses machine learning techniques to predict the development of type 2 diabetes mellitus (T2DM). Data generated from an oral glucose tolerance test (OGTT) was used to develop a predictive model based on the support vector machine (SVM). We trained and validated the models using the OGTT and demographic data of 1,492 healthy individuals collected during the San Antonio Heart Study. This study collected plasma glucose and insulin concentrations before glucose intake and at three time-points thereafter (30, 60 and 120 min). Furthermore, personal information such as age, ethnicity and body-mass index was also a part of the dataset. Using 11 oral glucose tolerance test (OGTT) measurements, we have deduced 61 features, which are then assigned a rank and the top ten features are shortlisted using Minimum Redundancy Maximum Relevance feature selection algorithm. All possible combinations of the 10 best ranked features were used to generate SVM based prediction models. This research shows that an individuals plasma glucose levels, and the information derived therefrom have the strongest predictive performance for the future development of T2DM. Significantly, insulin and demographic features do not provide additional performance improvement for diabetes prediction. The results of this work identify the parsimonious clinical data needed to be collected for an efficient prediction of T2DM. Our approach shows an average accuracy of 96.80 % and a sensitivity of 80.09 % obtained on a holdout set.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: machine learning (classical)
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Machine learning reveals time-varying microbial predictors with complex effects on glucose regulation
O. Aasmets, K. Lüll, … E. Org·bioRxiv·Aug 13, 2020
- Machine Learning in Multi-Omics Data to Assess Longitudinal Predictors of Glycaemic Health
Laurie Prélot, Harmen H. M. Draisma, … Inga Prokopenko·bioRxiv·Dec 13, 2018
- Development and validation of a type 2 diabetes machine learning classification model for EHR-based diagnostics and clinical decision support
Victor Glanz, Vladimir M. Dudenkov, Alexey Velikorodny·bioRxiv·Oct 8, 2022
- Development and validation of DNA Methylation scores in two European cohorts augment 10-year risk prediction of type 2 diabetes
Yipeng Cheng, Danni A. Gadd, … Riccardo Emilio Marioni·Nature AgingPeer-reviewed·Apr 6, 2023
- A Machine Learning-based Framework to Identify Type 2 Diabetes through Electronic Health Records
Tao Zheng, Wei Xie, … You Chen·International Journal of Medical InformaticsPeer-reviewed·Jan 1, 2017
- Nationwide prediction of type 2 diabetes comorbidities
Piotr Dworzyński, Martin Aasbrenn, … Tune H. Pers·Scientific ReportsPeer-reviewed·Feb 4, 2020